Key Insights

Highlights

Success Rate

86% trial completion

Published Results

19 trials with published results (17%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.0%

8 terminated out of 114 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

12%

14 trials in Phase 3/4

Results Transparency

40%

19 of 48 completed with results

Key Signals

19 with results86% success

Data Visualizations

Phase Distribution

65Total
Not Applicable (30)
Early P 1 (1)
P 1 (6)
P 2 (14)
P 3 (3)
P 4 (11)

Trial Status

Completed48
Recruiting25
Unknown14
Not Yet Recruiting10
Terminated8
Withdrawn5

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 48 completed trials

Clinical Trials (114)

Showing 20 of 20 trials
NCT03577431Phase 1Active Not RecruitingPrimary

Liver Transplantation With Tregs at MGH

NCT06280950Phase 2RecruitingPrimary

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

NCT03819322Phase 2CompletedPrimary

The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients

NCT07549503Phase 2Not Yet RecruitingPrimary

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

NCT04471441Phase 4CompletedPrimary

Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.

NCT07519057Not ApplicableNot Yet Recruiting

Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients

NCT06075745Phase 2RecruitingPrimary

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

NCT05087550CompletedPrimary

Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation

NCT06254248Phase 2RecruitingPrimary

Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

NCT06342557RecruitingPrimary

Transitional ePRO Diary Liver (Transitional-ePRO)

NCT01172691Phase 2CompletedPrimary

Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

NCT06832189Phase 1RecruitingPrimary

EVR and EPO for Liver Transplant Tolerance

NCT06043531Not ApplicableCompletedPrimary

Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients

NCT05506878Not ApplicableRecruiting

Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

NCT07305012Not ApplicableRecruitingPrimary

Feasibility and Acceptability of a New Tool Promoting a Healthy Lifestyle in Liver and Kidney Transplant Recipients

NCT07300709Not ApplicableNot Yet Recruiting

Renal Histopathology and Transcriptomic Analysis in Hepatorenal Syndrome During Liver Transplantation

NCT07291258Recruiting

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

NCT07267208Phase 2Not Yet Recruiting

A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant Patients

NCT04204850Phase 2Recruiting

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

NCT07216508RecruitingPrimary

Liver Transplant CGM

Scroll to load more

Research Network

Activity Timeline